Hemicrania continua responsive to botulinum toxin type A: A case report

Headache

Volumn 53, Issue 5, 2013, Pages 831-833

  Khalil, Modar ^a   Ahmed, Fayyaz ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

botulinum toxin; headache; hemicrania continua; indomethacin

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN A; DICLOFENAC; IBUPROFEN; INDOMETACIN; NAPROXEN; PANTOPRAZOLE; RANITIDINE; TOPIRAMATE;

ADULT; CASE REPORT; CONJUNCTIVA DISEASE; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL NEUROIMAGING; HEMICRANIA CONTINUA; HUMAN; LACRIMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHINORRHEA; STOMACH DISEASE; SUPERSENSITIVITY; TREATMENT RESPONSE; VOMITING;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BOTULINUM TOXINS, TYPE A; FEMALE; GASTRITIS; HEADACHE; HUMANS; INDOMETHACIN; NEUROMUSCULAR AGENTS;

EID: 84876783469     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12086     Document Type: Review

References (21)

1. Headache Classification Committee of the International Headache Society. The international classification of headache disorders 2nd edition. Cephalalgia. 2004; 24: 1-160.
2. Pasqier F, Leys D, Petit H,. Hemicrania continua: The first bilateral case. Cephalalgia. 1987; 7: 169-170.
3. Newman LC, Lipton RB, Russell M, Solomon S,. Hemicrania continua: Attacks may alternate sides. Headache. 1992; 32: 237-238.
4. Bordini C, Antonaci F, Stovner LJ, Schrader H, Sjaastad O,. "Hemicrania continua": A clinical review. Headache. 1991; 31: 20-26.
5. Peres MFP, Silberstein SD, Nahmias S, Sechter AL, Youssef I, Rozen TED,. Hemicrania continua is not that rare. Neurology. 2001; 57: 948-951.
6. Pareja JA, Sjaastad O,. Chronic paroxysmal hemicrania and hemicrania continua. Interval between indomethacin administration and response. Headache. 1996; 36: 20-23.
7. Newman LC, Lipton RB, Solomon S,. Hemicrania continua: Ten new cases and a review of the literature. Neurology. 1994; 44: 2111-2114.
8. Trucco M, Antonaci F, Sandrini G,. Hemicrania continua: A case responsive to piroxicam-beta-cyclodextrin. Headache. 1992; 32: 39-40.
9. Espada F, Escalza I, Morales-Asín F, Nasas I, Iñiguez C, Mauri JA,. Hemicrania continua: Nine new cases. Cephalalgia. 1999; 19: 442.
10. Rozen TD,. Melatonin responsive hemicrania continua. Headache. 2006; 46: 1203-1204.
11. Camarada C, Camarada R, Monastero R,. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate. Two case reports. Clin Neurol Neurosurg. 2008; 110: 88-91.
12. Afridi SK, Shields KG, Bhola R, Goadsby PJ,. Greater occipital nerve injection in primary headache syndromes: Prolonged effects from a single injection. Pain. 2006; 122: 126-129.
13. Burns B, Watkins L, Goadsby PJ,. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: Long-term follow-up of a cross over study. Lancet. 2008; 7: 1001-1012.
14. Schwedt T, Dodick D, Trentman T, Zimmerman R,. Occipital nerve stimulation for chronic cluster headache and hemicrania continua: Pain relief and persistence of autonomic features. Cephalalgia. 2006; 26: 1025-1027.
15. Matharu MS, Cohen AS, McGonigle DJ, Ward N, Frackowiak RSJ, Goadsby PJ,. Posterior hypothalamus and brainstem activation in hemicrania continua. Headache. 2004; 44: 747-761.
16. Garza I, Cutrer FM,. Pain relief and persistence of dysautonomic features in a patient with hemicrania continua responsive to botulinum toxin type A. Cephalalgia. 2010; 30: 500-503.
17. Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for the treatment of chronic migraine: Results from double-blind, randomised, placebo-controlled phases of the PREEMPT 2 trial. Cephalalgia. 2010; 30: 804-814.
18. Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for the treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010; 50: 921-936.
19. Aoki KR,. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005; 26: 785-793.
20. Irimia P, Arbizu J, Prieto E, Fernández-Torrón R, Martínez-Vila E,. Activation of the brainstem but not of the hypothalamus in hemicrania continua without autonomic symptoms. Cephalalgia. 2009; 29: 974-979.
21. Malick A, Burstein R,. Cells of origin of the trigeminohypothalamic tract in the rat. J Comp Neurol. 1988; 400: 125-144.